blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2979688

EP2979688 - Composition containing Apomorphine and a Divalent Metal Cation [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.12.2016
Database last updated on 17.09.2024
Most recent event   Tooltip23.12.2016Application deemed to be withdrawnpublished on 25.01.2017  [2017/04]
Applicant(s)For all designated states
Britannia Pharmaceuticals Ltd.
200 Longwater Avenue, Green Park
Reading
Berkshire RG2 6 GP / GB
[N/P]
Former [2016/37]For all designated states
Britannia Pharmaceuticals Limited
200 Longwater Avenue, Green Park
Reading
Berkshire RG2 6 GP / GB
Former [2016/05]For all designated states
Britannia Pharmaceuticals Limited
Park View House
65 London Road
Newbury, Berkshire RG14 1JN / GB
Inventor(s)01 / Leader, Ian Philip
9 Lymington Rise
Four Marks, Hampshire GU34 5BA / GB
 [2016/05]
Representative(s)Kernebeck, Thomas
Kernebeck Patentanwalts GmbH
Stiftstraße 2
60313 Frankfurt am Main / DE
[2016/05]
Application number, filing date14002689.901.08.2014
[2016/05]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2979688
Date:03.02.2016
Language:EN
[2016/05]
Search report(s)(Supplementary) European search report - dispatched on:EP16.01.2015
ClassificationIPC:A61K9/08, A61K47/02, A61K31/473, A61P25/16
[2016/05]
CPC:
A61K31/473 (EP,KR,US); A61K9/08 (KR,US); A61K33/06 (EP,US);
A61K47/02 (EP,KR,US); A61K47/18 (KR); A61K47/20 (EP,KR,US);
A61K9/0019 (EP,KR,US); A61P25/16 (EP,KR); A61P7/00 (EP) (-)
C-Set:
A61K31/473, A61K2300/00 (EP,US);
A61K33/06, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/05]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:Zusammensetzung mit Apomorphin und divalentem Metallkation[2016/05]
English:Composition containing Apomorphine and a Divalent Metal Cation[2016/05]
French:Composition contenant de l'apomorphine et un cation de métal divalent[2016/05]
Examination procedure04.08.2016Application deemed to be withdrawn, date of legal effect  [2017/04]
09.09.2016Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2017/04]
Fees paidPenalty fee
Additional fee for renewal fee
31.08.201603   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2011111011  (GIOVINAZZO ANTHONY JOHN [CA], et al) [Y] 6,7* paragraph [0013]; claims 1, 3, 15 *;
 [IAY]EP2545905  (BRITANNIA PHARMACEUTICALS LTD [GB]) [I] 1-4,8,9,11,12,14,15 * paragraphs [0001] - [0003] - [0016] , [0 20] - [0025] - [0 30] - [0032]; claims 1, 7, 15, 16 * [A] 5,10,13 [Y] 6,7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.